Thompson Davis & Co’s Vaxart VXRT Stock Holding History

Thompson Davis & Co’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,000	Closed	-$10.2K	–	150
2024 Q3	$10.2K	Sell	12,000 -2,000	-14%	-$1.53K	0.01%	120
2024 Q2	$9.34K	Buy	+14,000	New	+$11.6K	0.01%	110

Other funds holding VXRT

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Thompson Davis & Co's VXRT Position: Q4 2024 in Review

Thompson Davis & Co sold out of Vaxart (VXRT) in Q4 2024, closing a stake of 12,000 shares — an estimated $10.2K sold.

Thompson Davis & Co first reported a position in VXRT in Q2 2024 and held it in 2 quarters. The position peaked at $10.2K in Q3 2024. 93 funds tracked by Wall St. Rank hold VXRT as of Q4 2024.

Thompson Davis & Co reported no remaining Vaxart position as of Q4 2024 after selling out during the quarter.
Thompson Davis & Co sold 12,000 Vaxart shares in Q4 2024, an estimated $10.2K.
Thompson Davis & Co first reported a position in Vaxart in Q2 2024 and held it in 2 quarters.
Thompson Davis & Co's Vaxart position peaked at $10.2K in Q3 2024.
93 funds tracked by Wall St. Rank held Vaxart as of Q4 2024.

Based on Thompson Davis & Co's 13F filing for Q4 2024, filed 3 Feb 2025.